Summit Partners Public Asset Management, LLC Legend Biotech Corp Transaction History

Summit Partners Public Asset Management, LLC

$2.79 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$55.06 - $69.99 $18.2 Million - $23.1 Million	-330,530 Reduced 58.4%	235,493 $13.2 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $9.02 Million - $11 Million	157,474 Added 38.54%	566,023 $34.1 Million
Q3 2023 Nov 14, 2023	BUY	$63.16 - $76.5 $25.8 Million - $31.3 Million	408,549 New	408,549 $27.4 Million

Others Institutions Holding LEGN

# of Institutions

225

Shares Held

74.3M

Call Options Held

279K

Put Options Held

350K

Price T Rowe Associates Inc Baltimore, MD

11.2M
Shares

$366 Million
0.06% of portfolio
Ra Capital Management, L.P. Boston, MA

7.51M
Shares

$246 Million
5.1% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

6.64M
Shares

$218 Million
7.41% of portfolio
Black Rock Inc. New York, NY

5.72M
Shares

$188 Million
0.01% of portfolio
Westfield Capital Management CO LP Boston, MA

5.04M
Shares

$165 Million
1.16% of portfolio

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account